Partner
CurrentNegotiated and prepared licensing deals for dozens of early-stage and maturing companies.Prepared and/or prosecuted thousands of patent applications in over 50 countries.Developed and managed clinically essential, worldwide patent portfolios for therapeutic antibodies and other pharmaceuticals for global and early-stage companies.Represented more than 10 distinct clinical diagnostic companies for a variety of platforms and technologies related to the detection of nucleic acids, peptides and small molecule markers.Strategically advised numerous pharma, diagnostic and medical device companies to successfully evaluate and acquire or divest intellectual property assets to optimize enterprise value during mergers and acquisitions.Advised on hundreds of IP diligence reviews for buyers, sellers, lenders and investors.